PharmaShots | Incisive News in 3 Shots

Subscribe Now

RNAi therapeutics

Top 20 RNAi Therapeutic Companies of 2024

Top 20 RNAi Therapeutic Companies of 2024

April 25, 2024

Alnylam Signs a License Agreement with PeptiDream to Develop and Commercialize Peptide-siRNA Conjugates for Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues

Alnylam Signs a License Agreement with PeptiDream to Develop and Commercialize Peptide-siRNA Conjugates for Delivery of RNAi Thera...

July 30, 2021

Regeneron Collaborates with Alnylam to Discover- Develop and Commercialize RNAi Therapeutics for Ophthalmic and CNS Disorders

Regeneron Collaborates with Alnylam to Discover- Develop and Commercialize RNAi Therapeutics for Ophthalmic and CNS Disorders

April 9, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us